Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

67 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours.
Bokemeyer C, Schmoll HJ, Harstrick A, Illiger HJ, Metzner B, Räth U, Hohnloser J, Clemm C, Berdel W, Siegert W, et al. Bokemeyer C, et al. Among authors: rath u. Eur J Cancer. 1993;29A(16):2225-31. doi: 10.1016/0959-8049(93)90211-w. Eur J Cancer. 1993. PMID: 8110490 Clinical Trial.
Cisplatin/etoposide/ifosfamide stepwise dose escalation with concomitant granulocyte/macrophage-colony-stimulating factor for patients with far-advanced testicular carcinoma.
Harstrick A, Schmoll HJ, Bokemeyer C, Metzner B, Illiger HJ, Berdel W, Ostermann H, Manegold C, Räth U, Siegert W, et al. Harstrick A, et al. Among authors: rath u. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S198-202. doi: 10.1007/BF01613227. J Cancer Res Clin Oncol. 1991. PMID: 1665492 Clinical Trial.
A randomized trial of cisplatin, etoposide and bleomycin (PEB) versus carboplatin, etoposide and bleomycin (CEB) for patients with 'good-risk' metastatic non-seminomatous germ cell tumors.
Bokemeyer C, Köhrmann O, Tischler J, Weissbach L, Räth U, Haupt A, Schöffski P, Harstrick A, Schmoll HJ. Bokemeyer C, et al. Among authors: rath u. Ann Oncol. 1996 Dec;7(10):1015-21. doi: 10.1093/oxfordjournals.annonc.a010493. Ann Oncol. 1996. PMID: 9037359 Free article. Clinical Trial.
Pen-based remote data entry system. A pilot clinical trial.
Beinlich I, Bokemeyer C, Räth U, Walter-Kirst R, Hartlapp J, Muschiol J, Fraass U, Schneider HT. Beinlich I, et al. Among authors: rath u. Arzneimittelforschung. 1993 Mar;43(3):399-404. Arzneimittelforschung. 1993. PMID: 8489574 Clinical Trial.
Evaluation of the importance and relevance of dose intensity using epirubicin and cyclophosphamide in metastatic breast cancer: interim analysis of a prospective randomized trial.
Marschner N, Kreienberg R, Souchon R, Räth U, Eggeling B, Voigtmann R, Ruffert K, Schütte M, Ammon A, Kesztyüs T, et al. Marschner N, et al. Among authors: rath u. Semin Oncol. 1994 Feb;21(1 Suppl 1):10-6. Semin Oncol. 1994. PMID: 8153652 Clinical Trial. No abstract available.
'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.
Cunningham D, Zalcberg JR, Rath U, Olver I, Van Cutsem E, Svensson C, Seitz JF, Harper P, Kerr D, Perez-Manga G, et al. Cunningham D, et al. Among authors: rath u. Eur J Cancer. 1995 Nov;31A(12):1945-54. doi: 10.1016/0959-8049(95)00502-1. Eur J Cancer. 1995. PMID: 8562146 Clinical Trial.
67 results